{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T06:47:29Z","timestamp":1782542849141,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cancerepidemiology.net","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.canep.2016.06.007","type":"journal-article","created":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T18:33:02Z","timestamp":1467657182000},"page":"35-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Survival among clinical stage I\u2013III rectal cancer patients treated with different preoperative treatments: A population-based comparison"],"prefix":"10.1016","volume":"43","author":[{"given":"Ines","family":"Joye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Silversmit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Van Eycken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"Debucquoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Vandendael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddy","family":"Penninckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Haustermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2016.06.007_bib0005","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources: methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canep.2016.06.007_bib0010","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/bjs.1800691019","article-title":"The mesorectum in rectal cancer surgery \u2212the clue to pelvic recurrence?","volume":"69","author":"Heald","year":"1982","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.canep.2016.06.007_bib0015","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0140-6736(86)91510-2","article-title":"Recurrence and survival after total mesorectal excision for rectal cancer","volume":"1","author":"Heald","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.canep.2016.06.007_bib0020","first-page":"335","article-title":"Total mesorectal excision in the operative treatment of carcinoma of the rectum","volume":"181","author":"Enker","year":"1995","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.canep.2016.06.007_bib0025","doi-asserted-by":"crossref","unstructured":"Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N. Engl. J. Med. 336 (1997) 980\u2013987.","DOI":"10.1056\/NEJM199704033361402"},{"key":"10.1016\/j.canep.2016.06.007_bib0030","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1200\/JCO.2005.08.144","article-title":"Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate","volume":"23","author":"Folkesson","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canep.2016.06.007_bib0035","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa010580","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer","volume":"345","author":"Kapiteijn","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canep.2016.06.007_bib0040","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial","volume":"12","author":"van Gijn","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canep.2016.06.007_bib0045","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1200\/JCO.2009.22.0467","article-title":"Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03","volume":"27","author":"Roh","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canep.2016.06.007_bib0050","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1200\/JCO.2011.40.1836","article-title":"Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO\/ARO\/AIO-94 randomized phase III trial after a median follow-up of 11 years","volume":"30","author":"Sauer","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canep.2016.06.007_bib0055","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S1470-2045(14)71199-4","article-title":"Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data","volume":"16","author":"Breugom","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canep.2016.06.007_bib0060","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1470-2045(13)70599-0","article-title":"Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study","volume":"15","author":"Bosset","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canep.2016.06.007_bib0065","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/DCR.0b013e318197d13c","article-title":"Differences between clinical trial participants and patients in a population-based registry: the German Rectal Cancer Study vs the Rostock Cancer Registry","volume":"52","author":"Kalata","year":"2009","journal-title":"Dis. Colon Rectum"},{"key":"10.1016\/j.canep.2016.06.007_bib0070","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1200\/JCO.2003.08.010","article-title":"Participation of patients 65 years of age or older in cancer clinical trials","volume":"21","author":"Lewis","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canep.2016.06.007_bib0075","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1200\/JCO.2005.00.141","article-title":"Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials","volume":"23","author":"Townsley","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canep.2016.06.007_bib0080","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.ejca.2008.05.004","article-title":"Improved overall survival for patients with rectal cancer since 1990: the effects of TME surgery and pre-operative radiotherapy","volume":"44","author":"Den Dulk","year":"2008","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canep.2016.06.007_bib0085","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.ejso.2014.08.481","article-title":"Preoperative treatment selection in rectal cancer: a population-based cohort study","volume":"40","author":"Elliot","year":"2014","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.canep.2016.06.007_bib0090","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/bjs.4978","article-title":"Population-based study of short- and long-term survival from colorectal cancer in Denmark, 1977\u20131999","volume":"92","author":"Iversen","year":"2005","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.canep.2016.06.007_bib0095","first-page":"1714","article-title":"Nationwide improvement of rectal cancer treatment outcomes in Norway","volume":"54","author":"Guren","year":"2015","journal-title":"1993-2010. Acta. Oncol."},{"key":"10.1016\/j.canep.2016.06.007_bib0100","unstructured":"Intermutualistic Agency. http:\/\/www.nic-ima.be\/ (accessed 08.03.16)."},{"key":"10.1016\/j.canep.2016.06.007_bib0105","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwm324","article-title":"Immortal time bias in pharmaco-epidemiology","volume":"167","author":"Suissa","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.canep.2016.06.007_bib0110","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/01.dcr.0000436362.81611.de","article-title":"Outcomes of multimodality therapies for patients with stage II or III rectal cancer in California, 1994\u20132009","volume":"56","author":"Cho","year":"2013","journal-title":"Dis. Colon Rectum"},{"key":"10.1016\/j.canep.2016.06.007_bib0115","article-title":"Effectiveness of neoadjuvant concurrent chemoradiotherapy versus up-front proctectomy in clinical stage II\u2013III rectal cancer: a population-based study","author":"Ke","year":"2014","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"10.1016\/j.canep.2016.06.007_bib0120","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1200\/JCO.2002.08.062","article-title":"Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study","volume":"20","author":"Neugut","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canep.2016.06.007_bib0125","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/bjs.5506","article-title":"Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer","volume":"93","author":"Bujko","year":"2006","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.canep.2016.06.007_bib0130","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1200\/JCO.2012.42.9597","article-title":"Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: trans-Tasman Radiation Oncology Group trial 01.04","volume":"30","author":"Ngan","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canep.2016.06.007_bib0135","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0959-8049(03)00493-3","article-title":"Improved survival of patients with rectal cancer since 1980: a population-based study","volume":"39","author":"Martijn","year":"2003","journal-title":"Eur. J. Cancer."},{"key":"10.1016\/j.canep.2016.06.007_bib0140","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/DCR.0b013e318210c067","article-title":"The effects of short-course preoperative irradiation on local recurrence rate and survival in rectal cancer: a population-based nationwide study","volume":"54","author":"Tiefenthal","year":"2011","journal-title":"Dis. Colon Rectum"},{"key":"10.1016\/j.canep.2016.06.007_bib0145","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.ejca.2007.06.008","article-title":"Comorbidity in older surgical cancer patients: influence on patient care and outcome","volume":"43","author":"Janssen-Heijnen","year":"2007","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canep.2016.06.007_bib0150","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1016\/j.ejca.2005.10.032","article-title":"Elderly patients with rectal cancer have a higher risk of treatment-related complications and a poorer prognosis than younger patients: a population-based study","volume":"42","author":"Shahir","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canep.2016.06.007_bib0155","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1470-2045(08)70129-3","article-title":"Controversies of total mesorectal excision for rectal cancer in elderly patients","volume":"9","author":"Rutten","year":"2008","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canep.2016.06.007_bib0160","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.critrevonc.2005.04.008","article-title":"Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach","volume":"55","author":"Janssen-Heijnen","year":"2005","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.canep.2016.06.007_bib0165","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/bjs.5679","article-title":"The Swedish rectal cancer registry","volume":"94","author":"Pahlman","year":"2007","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.canep.2016.06.007_bib0170","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/DCR.0b013e3181cf7e27","article-title":"A population-based study on outcome in relation to the type of resection in low rectal cancer","volume":"53","author":"Anderin","year":"2010","journal-title":"Dis. Colon Rectum"},{"key":"10.1016\/j.canep.2016.06.007_bib0175","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1093\/annonc\/mds236","article-title":"ESMO Consensus Guidelines for management of patients with colon and rectal cancer a personalized approach to clinical decision making","volume":"23","author":"Schmoll","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canep.2016.06.007_bib0180","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1470-2045(13)70599-0","article-title":"Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study","volume":"15","author":"Bosset","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canep.2016.06.007_bib0185","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S1470-2045(14)71199-4","article-title":"Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data","volume":"16","author":"Breugom","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canep.2016.06.007_bib0190","doi-asserted-by":"crossref","unstructured":"F. Penninckx, S. Roels, D. Leonard, et al. Kwaliteit van rectale kankerzorg, fase 1: Een praktijkrichtlijn voor rectale kanker. Good Clinical Practice (GCP). Brussel: Federaal Keniscentrum voor de Gezondheidszorg (KCE); 2007. KCE reports 69A. https:\/\/kce.fgov.be\/nl\/publication\/report\/kwaliteit-van-rectale-kankerzorg-fase-1-een-praktijkrichtlijn-voor-rectale-kanker.","DOI":"10.57598\/R69A"},{"key":"10.1016\/j.canep.2016.06.007_bib0195","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/SLA.0b013e31820b8d52","article-title":"Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study","volume":"253","author":"Taylor","year":"2011","journal-title":"Ann. Surg."},{"key":"10.1016\/j.canep.2016.06.007_bib0200","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1158\/1078-0432.CCR-07-0343","article-title":"Caspase-3 activity predicts local recurrence in rectal cancer","volume":"13","author":"de Heer","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canep.2016.06.007_bib0205","doi-asserted-by":"crossref","first-page":"6956","DOI":"10.1158\/1078-0432.CCR-09-1165","article-title":"PIK3CA mutations predict local recurrences in rectal cancer patients","volume":"15","author":"He","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canep.2016.06.007_bib0210","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1245\/s10434-006-9171-0","article-title":"Prognostic significance of circumferential resection margin following total mesorectal excision and adjuvant chemoradiotherapy in patients with rectal cancer","volume":"14","author":"Baik","year":"2007","journal-title":"Ann. Surg. Oncol."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782116300789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782116300789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T23:47:58Z","timestamp":1748994478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782116300789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":42,"alternative-id":["S1877782116300789"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2016.06.007","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival among clinical stage I\u2013III rectal cancer patients treated with different preoperative treatments: A population-based comparison","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2016.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}